- Home
- CPBI vs SRTS Comparison
CPBI vs SRTS Comparison
Compare CPBI & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPBI | SRTS |
|---|---|---|
| Founded | 2023 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 79.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CPBI | SRTS |
|---|---|---|
| Price | $17.51 | $5.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 3.3K | ★ 122.2K |
| Earning Date | 02-10-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.32 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | $19,961,000.00 | ★ $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | $18.22 | ★ N/A |
| Revenue Growth | ★ 9.30 | N/A |
| 52 Week Low | $13.00 | $3.03 |
| 52 Week High | $17.70 | $9.08 |
Technical Indicators
Market Signals| Indicator | CPBI | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 60.40 | 63.29 |
| Support Level | $16.86 | $4.64 |
| Resistance Level | $17.70 | $5.36 |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 77.38 | 69.75 |
Price Performance
Historical ComparisonAbout CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.